How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

946 results for

Anxiety Non-pharmacologic Management

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Guidance on competencies for management of cancer pain in adults

of adverse effects ? Demonstrates recognition of the importance of non-pharmacological approaches such as physiotherapy, use of aids and adaptations, cognitive interventions, and role of TENS and acupuncture (even though the evidence base may be weak) ? Demonstrates the ability to perform neurolytic blockade (including autonomic, peripheral, regional and spinal techniques) in the management of cancer pain ? Demonstrates the ability to set up and manage external and internal implantable drug delivery (...) Guidance on competencies for management of cancer pain in adults Contents Introduction A: Core competencies for practitioners in Pain Medicine B: Competencies for practitioners in Pain Medicine who are involved in delivering a cancer pain service Appendix: Supporting information Guidance on competencies for management of Cancer Pain in adults Reviewed 2016 Page 2 4 6 9 Endorsed by: Introduction Pain affects half of all patients at diagnosis of cancer and affects up to 75% of patients

2016 Faculty of Pain Medicine

82. Acute pain management: scientific evidence, fourth edition, 2015

the status of each key message in comparison with the previous edition (eg, new, unchanged, strengthened, qualified, or reversed). The document addresses all aspects of acute pain management. There are sections on: the physiology, psychology and the assessment of acute pain; analgesic medicines and routes and techniques of their administration (eg, regional techniques, patient-controlled analgesia [PCA]); and non-pharmacological techniques (eg, physical therapies, acupuncture and psychological techniques (...) opinion. In 1999, the first edition of Acute pain management: scientific evidence was written by a multidisciplinary committee under the guidance of Michael Cousins and published by the National Health and Medical Research Council (NHMRC). As there has been a substantial increase in the quantity and quality of publications about acute pain management, the Australian and New Zealand College of Anaesthetists (ANZCA) and its Faculty of Pain Medicine (FPMANZCA) have taken responsibility for revising

2016 MJA Clinical Guidelines

83. KHA-CARI guideline recommendations for the diagnosis and management of autosomal dominant polycystic kidney disease

that the indications for urological intervention forstoneremovalinADPKDdependontheclinicalcircum- stances. If required, percutaneous nephrolithotomy, extra- corporeal shockwave lithotripsy or ureteroscopy with laser lithotripsymaybeconsidered. MANAGEMENTOFCHRONICPAIN Guidelinerecommendations (1) Werecommendthatcliniciansshouldincludetheevalua- tion of pain in patients with ADPKD during clinic visits (1D). (2) We recommend that patients be involved in the manage- ment of their pain, and that non-pharmacological (...) - sion or mechanical back pain from increased kidney mass). Thus,painduetocystinfectionistypicallylocalizedandasso- ciated with fever, elevated in?ammatory markers, positive urine cultures and positive MRI or ?uorodeoxyglucose- positronemissiontomographyimaging. ? The initial assessment, and ongoing monitoring, should indicate the appropriate management of chronic pain in ADPKD. Management should be stepwise, involving non- pharmacological, pharmacological and possibly invasive interventions for cyst

2016 KHA-CARI Guidelines

84. Management of Behavioural and Psychological Symptoms of Dementia (BPSD)

was found among dementia guidelines for the majority of specific practice recommendations with regard to non-pharmacological interventions. Pharmacological management was proposed as second-line treatment, with agreement for the use of a selection of antipsychotics based on supporting evidence 65 together with guidance for timely discontinuation by some of the guidelines. 66, 67 BPSD rating scales BPSD severity can range from mild BPSD to extreme BPSD, which can be very difficult to manage, and could (...) care providers and all health professionals involved in care of older people with dementia is important. • Non-pharmacological individualised strategies should be the first line of management of BPSD used by the family, relatives and paid carers in the community and in the hospital setting. • Judicious use of medications by people with expertise in this area may be necessary as an adjuvant therapy or when non-pharmacological management has failed. Careful monitoring for side effects is an essential

2016 Australian and New Zealand Society for Geriatric Medicine

85. Guideline on the management of premature ovarian insufficiency

Excellence, 2013) or menopause (de Villiers, et al., 2013). Guidance on management of Turner Syndrome was available but this concentrated on the other medical aspects of the syndrome and did not comprehensively address POI (Bondy and Turner Syndrome Study Group, 2007). Guideline development The Reproductive Endocrinology Special Interest Group of ESHRE initiated a guideline on POI. Membership of the Guideline development group was drawn from the Special Interest Group and the wider membership of ESHRE (...) Guideline on the management of premature ovarian insufficiency 1 POI Guideline Development Group December 2015 Management of women with premature ovarian insufficiency Guideline of the European Society of Human Reproduction and Embryology 2 Disclaimer The European Society of Human Reproduction and Embryology (hereinafter referred to as 'ESHRE') developed the current clinical practice guideline, to provide clinical recommendations to improve the quality of healthcare delivery within the European

2015 European Society of Human Reproduction and Embryology

86. A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia

of the cost of non-pharmacological interventions 62 Methods 62 Results 62 Cost-effectiveness analysis of non-pharmacological interventions for managing agitation 62 Methods 62 Results 63 Analysis of health and social care costs associated with agitation 66 Methods 66 Results 66 Analysis of health-related quality of life associated with agitation 71 Methods 71 Results 71 Cost–utility analysis of non-pharmacological interventions for managing agitation 75 Introduction 75 Methods 75 Model structure 75 (...) and behavioural management techniques for managing neuropsychiatric symptoms were effective treatments whose bene?ts lasted for months. Music therapy (and possibly other sensory stimulation approaches) were useful during the treatment session but had no longer-term effects; and interventions that changed the visual environment looked promising. A more recent, very broad review of interventions for agitation selected 47 trials of pharmacological and non-pharmacological treatment for consideration and concluded

2014 NIHR HTA programme

87. Acute pain management: scientific evidence (3rd Edition)

anaesthetics 204 7.5.5 Safety 205 References 208 8. NON-PHARMACOLOGICAL TECHNIQUES 225 8.1 Psychological interventions 225 8.1.1 Provision of information 225 8.1.2 Stress and tension reduction 226 8.1.3 Attentional techniques 227 8.1.4 Cognitiv e-behavioural interventions 228 8.2 Transcutaneous electrical nerve stimulation 230 8.3 Acupuncture 231 8.4 Other physical therapies 232 8.4.1 Manual and massage therapies 232 8.4.2 Heat and cold 232 8.4.3 Other therapies 232 References 233 Acute Pain Management (...) : Scientific Evidence xv CONTENTS 9. SPECIFIC CLINICAL SITUATIONS 237 9.1 Postoperative pain 237 9.1.1 Risks of acute postoperative neuropathic pain 237 9.1.2 Acute postamputation pain syndromes 238 9.1.3 Other postoperative pain syndromes 240 9.1.4 Day-stay or short-stay surgery 242 9.1.5 Cranial neurosurgery 245 9.2 Acute pain following spinal cord injury 247 9.3 Acute burn injury pain 249 9.3.1 Management of procedural pain 250 9.3.2 Non-pharmacological pain management 251 9.4 Acute back pain 252 9.5

2015 National Health and Medical Research Council

88. Virtual Reality Distraction for Procedural Pain Management and Anxiety in Children With Burn Injuries : A Pilot Study

few studies have tested the efficacy of distraction by virtual reality on procedural pain and anxiety in children with burn injuries. The aim of this study is to assess the feasibility and preliminary efficacy of a virtual reality prototype developed specifically for the hydrotherapy room of children under seven years old for the relief of procedural pain and anxiety in children with burn injuries. HYPOTHESES: a) VR distraction is a feasible non-pharmacological intervention for pain management (...) : April 2017 Keywords provided by Sylvie Le May, St. Justine's Hospital: Virtual reality Immersive distraction Virtual world Virtual environment Procedural pain Procedural anxiety Acute pain Pain management Anxiety Children, Child Kid, Kids Pediatric, Pediatrics Young children Burns Burn injuries Burn unit Hydrotherapy Burn dressing Non-pharmacological Clinical Research Nursing Practice Additional relevant MeSH terms: Layout table for MeSH terms Anxiety Disorders Burns Pain, Procedural Mental

2016 Clinical Trials

89. Management of gag reflex for patients undergoing dental treatment. (Abstract)

, acupressure, acupuncture, laser, and prosthetic devices. This is an update of the Cochrane Review first published in 2015.To assess the effects of pharmacological and non-pharmacological interventions for the management of gagging in people undergoing dental treatment.Cochrane Oral Health's Information Specialist searched the Cochrane Oral Health's Trials Register (to 18 March 2019), the Cochrane Central Register of Controlled Trials (CENTRAL; 2019, Issue 2) in the Cochrane Library (searched 18 March 2019 (...) on the included studies via Google Scholar. No restrictions were placed on the language or date of publication when searching the electronic databases.We included randomised controlled trials (RCTs), involving people who were given a pharmacological or non-pharmacological intervention to manage gagging that interfered with dental treatment. We excluded quasi-RCTs. We excluded trials with participants who had central or peripheral nervous system disorders, who had oral lesions or were on systemic medications

2020 The Cochrane database of systematic reviews

90. Monitoring and Management of Pediatric Patients Before, During, and After Sedation for Diagnostic and Therapeutic Procedures

pediatric providers updated information and guidance in delivering safe sedation to children. To cite: Coté CJ, Wilson S. Guidelines for Monitoring and Management of Pedi- atric Patients Before, During, and After Sedation for Diagnostic and Therapeutic Procedures: Update 2016. American Academy of Pediatric Dentistry, American Academy of Pediatrics. Pediatr Dent 2016;38(4):E13-E39.288 RECOMMENDATIONS: BEST PRACTICES REFERENCE MANUAL V 40 / NO 6 18 / 19 principles have been widely implemented and shown (...) Monitoring and Management of Pediatric Patients Before, During, and After Sedation for Diagnostic and Therapeutic Procedures AMERICAN ACADEMY OF PEDIATRIC DENTISTRY RECOMMENDATIONS: BEST PRACTICES 287 Introduction The number of diagnostic and minor surgical procedures per- formed on pediatric patients outside of the traditional operating room setting has increased in the past several decades. As a consequence of this change and the increased awareness of the importance of providing analgesia

2016 American Academy of Pediatric Dentistry

91. How should we manage information needs, family anxiety, depression, and breathlessness for those affected by advanced disease: development of a Clinical Decision Support Tool using a Delphi design. (Full text)

How should we manage information needs, family anxiety, depression, and breathlessness for those affected by advanced disease: development of a Clinical Decision Support Tool using a Delphi design. Clinicians request guidance to aid the routine use and interpretation of Patient Reported Outcome Measures (PROMs), but tools are lacking. We aimed to develop a Clinical Decision Support Tool (CDST) focused on information needs, family anxiety, depression, and breathlessness (measured using (...) requirement. Assessment was recommended for increasing problems (i.e. scores), followed by non-pharmacological interventions and for breathlessness and depression, pharmacological interventions. Accompanying PROM implementation guidance was built based on the 8-step International Society for Quality of Life Research framework, as revised by nine (response rate 82%) experts.This CDST provides a straightforward guide to help support clinical care and improve evidence-based outcomes for patients

2015 BMC Medicine PubMed abstract

92. Critical Care Anxiety and Long-Term Outcomes Management

Details Study Description Go to Brief Summary: The aims of this study are to (1) test the benefits of a non-pharmacologic anxiety management approach with patients who are critically ill and/or traumatically injured during intensive care hospitalization and (2) test whether this approach reduces anxiety and improves engagement in rehabilitation therapies, shortens duration of hospitalization, and improves psychological and quality of life outcomes. Condition or disease Intervention/treatment Phase (...) Critical Care Anxiety and Long-Term Outcomes Management Critical Care Anxiety and Long-Term Outcomes Management - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Critical Care Anxiety and Long-Term Outcomes

2015 Clinical Trials

93. Efficacy of a minimal home-based psychoeducative intervention versus usual care for managing anxiety and dyspnoea in patients with severe chronic obstructive pulmonary disease: a randomised controlled trial protocol. (Full text)

have devastating consequences for both patients and their relatives. Non-pharmacological interventions, including cognitive-behavioural therapy, have been effective in managing anxiety and dyspnoea in patients with chronic obstructive pulmonary disease. However, the majority of existing interventions have tested the efficacy of relatively intensive comprehensive programmes and primarily targeted patients who have moderate pulmonary disease. We present the rationale and design for a trial (...) Efficacy of a minimal home-based psychoeducative intervention versus usual care for managing anxiety and dyspnoea in patients with severe chronic obstructive pulmonary disease: a randomised controlled trial protocol. In its final stages, chronic obstructive pulmonary disease is a severely disabling condition that is characterised by dyspnoea, which causes substantial anxiety. Anxiety is associated with an impaired quality of life and increased hospital admissions. Untreated comorbid anxiety can

2015 BMJ open Controlled trial quality: uncertain PubMed abstract

94. What are dental non-attenders' preferences for anxiety management techniques? A cross-sectional study based at a dental access centre. (Full text)

anaesthesia for restorations or extractions. Those highly anxious were less likely to consider tell-show-do techniques (p=0.001) or watching explanatory videos (p=0.004) to be helpful for overcoming their anxieties than the low or moderate anxiety groups.People attending access centres may represent a group who are unwilling to explore non-pharmacological methods to overcome their anxieties. This supports the need for sedation to provide treatment. Future work may include exploring in more depth (...) What are dental non-attenders' preferences for anxiety management techniques? A cross-sectional study based at a dental access centre. Dental anxiety is a barrier to attendance. Dental non-attenders may seek emergency care and may prefer to receive anxiety management measures for treatment required. Little is known about the preferences of these dental non-attenders for different anxiety management techniques. Understanding such preferences may inform management pathways, improve experiences

2015 British Dental Journal PubMed abstract

95. Clinical management of perinatal anxiety disorders: A systematic review. (Full text)

Clinical management of perinatal anxiety disorders: A systematic review. In the last few decades, there has been a growing interest in anxiety disorders (AnxD) in the perinatal period. Although AnxD are diagnosed in 4-39% of pregnant women and in up to 16% of women after delivery, evidence on their clinical management is limited.A systematic review was conducted on pharmacological and non-pharmacological treatment of AnxD in the perinatal period. Relevant papers published from January 1st 2015

2015 Journal of Affective Disorders PubMed abstract

96. A systematic review of non pharmacological interventions for older adults with comorbid dementia and anxiety living in residential aged care

A systematic review of non pharmacological interventions for older adults with comorbid dementia and anxiety living in residential aged care Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne (...) will be used to account for anticipated heterogeneity. ">Effect models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one experimental group, we will correct the total number of control animals in the meta-analysis by dividing the number of animals in the control group by the number of treatment groups served. Where

2016 PROSPERO

97. Mindfulness Interventions for the Treatment of Post-Traumatic Stress Disorder, Generalized Anxiety Disorder, Depression, and Substance Use Disorders

and depression and included three studies using mindfulness-based cognitive therapy, three studies using mindfulness-based stress reduction and three studies using acceptance-based behavior therapy. Hayes-Skelton et al. 29 compared acceptance-based behavior therapy with applied relaxation in adult patients with principal diagnosis of GAD. Anxiety and QoL were assessed in this RCT. Hoge et al. 30 compared mindfulness-based stress reduction to stress management education in adult patients with current primary (...) anxiety and depressive symptoms when compared to a waiting list. Hayes-Skelton et al. 29 indicated that there was no statistically significant difference between acceptance-based behavior therapy and applied relaxation in clinician’s severity rating, Structured Interview Guide for the Hamilton Anxiety Rating Scale (HAM-A), and Quality of Life Inventory scales, while Hoge et al. 30 reported that there was no significant difference between mindfulness-based stress reduction and stress management

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

98. Management of Concussion-mild Traumatic Brain Injury (mTBI)

including topics such as stimulus control, use of caffeine/tobacco/alcohol and other stimulants b. Non-pharmacologic interventions such as sleep hygiene education, dietary modification, physical therapy (PT), relaxation and modification of the environment (for specific components for each symptom, see Appendix B: Clinical Symptom Management) c. Pharmacologic interventions as appropriate both for acute pain and prevention of headache attacks Weak for Reviewed, New-replaced c. Dizziness and Disequilibrium (...) to the original CPG. It provides best practice recommendations for the care of patients with a history of mTBI. While screening for and addressing co-occurring mental disorders is considered good clinical practice, specific guidance on management of co-occurring mental health conditions is beyond the scope of this VA/DoD Clinical Practice Guideline for the Management of Concussion-mild Traumatic Brain Injury February 2016 Page 13 of 133 CPG. Interested readers are referred to related VA/DoD CPGs (e.g

2016 VA/DoD Clinical Practice Guidelines

99. Assessment and Management of Pressure Injuries for the Interprofessional Team, Third Edition

(not recommended) lb ? Recommendation 3.7: Provide negative pressure wound therapy to people with stage 3 and 4 pressure injuries in exceptional circumstances, including enhance ment of quality of life and in accordance with other person-/family- centred preferences. V ? Recommendation 3.8: Collaborate with the person and his/her circle of care to implement a pressure injury self-management plan. la ? Recommendation 3.9: Implement a person-centred pain management plan using pharmacological and non (...) Assessment and Management of Pressure Injuries for the Interprofessional Team, Third Edition Clinical Best Practice Guidelines MAY 2016 Assessment and Management of Pressure Injuries for the Interprofessional T eam Third EditionDisclaimer Th ese guidelines are not binding on nurses, other health care professionals, or the organizations that employ them. Th e use of these guidelines should be fl exible, and based on individual needs and local circumstances. Th ey neither constitute a liability

2016 Registered Nurses' Association of Ontario

100. Pharmacological Management of Cancer Pain in Adults

impairment 133 2.5.4 Opioid metabolites in patients with renal impairment 137 2.5.5 Dosage recommendations 139 2.5.6 Non-opioid analgesics in renal failure 141 2.5.7 The use of opioids in patients receiving dialysis 141 2.6. The use of opioids in patients with hepatic impairment 142 2.6.1 Aetiology 142 2.6.2 Opioid metabolism and use in hepatic impairment 143 2.6.3 Non-opioid analgesics in hepatic impairment 146 2.7. Non-pharmacological approaches to the management of cancer pain 148 2.7.1 Radiotherapy (...) , Bruyère Continuing Care and Professor Mike Bennett, St. Gemma’s Professor of Palliative Medicine, Academic Unit of Palliative Care, Leeds Institute of Health Sciences, School of Medicine, University of Leeds who reviewed the guideline and provided feedback. We gratefully acknowledge the guidance of Professor Michael Barry from the Medicines Management Programme and Ms Michelle O’Neill, Senior Health Economist, HIQA, in relation to pharmacoeconomic considerations. We would also like to acknowledge

2015 National Clinical Guidelines (Ireland)

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>